1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Vaccine Delivery Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Device
6.1 Syringes
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Jet Injectors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Intramuscular Vaccination
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intradermal Vaccination
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Subcutaneous Vaccination
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Enesi Pharma Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Gerresheimer AG
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 INOVIO Pharmaceuticals
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 NanoPass
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Panacea Biotec Pharma Limited (Panacea Biotec)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Pharmajet Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Schott AG (Carl-Zeiss-Stiftung)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 Terumo Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Vaxxas
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
世界のワクチンデリバリーデバイス市場予測2023年-2028年 |
| 【英語タイトル】Vaccine Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
 | ・商品コード：IMARC23FE0155 ・発行会社（調査会社）：IMARC ・発行日：2023年2月1日 ・ページ数：137 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：医療機器 |
| Single User | USD2,999 ⇒換算￥455,848 | 見積依頼/購入/質問フォーム |
| Five User | USD3,999 ⇒換算￥607,848 | 見積依頼/購入/質問フォーム |
| Enterprisewide | USD4,999 ⇒換算￥759,848 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| IMARC社の調査レポートによると、世界のワクチンデリバリーデバイス市場規模は2022年70億ドルに達しました。今後、2028年には109億ドルまで拡大し、2023年から2028年の間に年平均7.5％で成長すると予測されます。本レポートでは、ワクチンデリバリーデバイスの世界市場について調査・分析し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、デバイス別（シリンジ、ジェットインジェクター、その他）分析、投与経路別（筋肉内ワクチン接種、皮内ワクチン接種、皮下接種、その他）分析、エンドユーザー別（病院、クリニック、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下の構成でお届けします。なお、本書には、Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc, Penumbra Inc., Spectranetics Corporation (Koninklijke Philips N.V.), Stryker Corporation, Teleflex Incorporated and Terumo Corporation.などの企業情報が含まれています。 ・序論 ・範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界のワクチンデリバリーデバイス市場規模：デバイス別 - シリンジの市場規模 - ジェットインジェクターの市場規模 - その他デバイスの市場規模 ・世界のワクチンデリバリーデバイス市場規模：投与経路別 - 筋肉内ワクチン接種における市場規模 - 皮内ワクチン接種における市場規模 - 皮下接種における市場規模 - その他投与経路における市場規模 ・世界のワクチンデリバリーデバイス市場規模：エンドユーザー別 - 病院における市場規模 - クリニックにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界のワクチンデリバリーデバイス市場規模：地域別 - 北米のワクチンデリバリーデバイス市場規模 - アジア太平洋のワクチンデリバリーデバイス市場規模 - ヨーロッパのワクチンデリバリーデバイス市場規模 - 中南米のワクチンデリバリーデバイス市場規模 - 中東・アフリカのワクチンデリバリーデバイス市場規模 ・SWOT分析 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global vaccine delivery devices market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
A vaccine is a biological substance used to protect individuals from bacterial illnesses by stimulating the immune response of the body against the disease. It helps the immune system to produce antibodies against the invading antigens when given at specific intervals. It can be delivered in the body through liposomes, microspheres, nanoparticles, dendrimers, micellar systems, immune stimulating complexes (ISCOMs), and plant-derived viruses. At present, there is a rise in the utilization of vaccine delivery devices due to the growing prevalence of infectious diseases across the globe.
Vaccine Delivery Devices Market Trends:
Technological advancements in the systematic delivery of vaccines, such as micro-needles and electroporation, represent one of the key factors driving the market. Moreover, there is an increase in the utilization of needle-free delivery systems as they decrease needle stick injuries and the vaccine antigen dose and enhance the vaccine immunogenicity. This, along with the rising research in the field of vaccines and the development of new vaccine delivery devices around the world, is propelling the growth of the market. In addition, governments of several countries are promoting immunization programs to prevent disabilities and deaths from vaccine-preventable diseases. This, coupled with the growing investments by non-governmental organizations (NGOs) for various vaccination programs and campaigns globally, is positively influencing the market. Besides this, key market players are focusing on novel delivery technologies that increase the therapeutic value of vaccines by reducing toxicity. Additionally, the expanding healthcare sector due to the increasing geriatric population and easy access to medical products and services is bolstering the market growth. Furthermore, the outbreak of coronavirus disease (COVID-19) is augmenting the sales of vaccine delivery devices worldwide.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine delivery devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device, route of administration and end user.
Breakup by Device:
Syringes
Jet Injectors
Others
Breakup by Route of Administration:
Intramuscular Vaccination
Intradermal Vaccination
Subcutaneous Vaccination
Others
Breakup by End User:
Hospitals
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Becton Dickinson and Company, Enesi Pharma Limited, Gerresheimer AG, INOVIO Pharmaceuticals, NanoPass, Panacea Biotec Pharma Limited (Panacea Biotec), Pharmajet Inc., Schott AG (Carl-Zeiss-Stiftung), Terumo Corporation and Vaxxas.
Key Questions Answered in This Report:
How has the global vaccine delivery devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global vaccine delivery devices market?
What are the key regional markets?
What is the breakup of the market based on the device?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global vaccine delivery devices market and who are the key players?
What is the degree of competition in the industry?
❖ レポートの目次 ❖
| ★調査レポート[世界のワクチンデリバリーデバイス市場予測2023年-2028年] (コード：IMARC23FE0155)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のワクチンデリバリーデバイス市場予測2023年-2028年]についてメールでお問い合わせ |
